propidium has been researched along with isatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glover, V; Igosheva, N; Lorz, C; Mehmet, H; O'Conner, E | 1 |
Ge, Y; Hou, L; Ju, C; Song, J; Yue, W; Zhang, J | 1 |
2 other study(ies) available for propidium and isatin
Article | Year |
---|---|
Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
Topics: Annexin A5; Antiparkinson Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isatin; Monoamine Oxidase Inhibitors; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Parkinson Disease; Propidium; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzimidazoles; Blotting, Western; Caspase 3; Cell Line, Tumor; Coloring Agents; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Isatin; Neuroblastoma; Phosphorylation; Propidium; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staining and Labeling; Vascular Endothelial Growth Factor A | 2008 |